Blackfin’s new Aura optical beta-titanium styles are brightened by rims derived from a colourful nylon lens. The updated styles are also thinner, combining the two materials in a functional design ensuring greater stability and simplicity by pressure-mounting the lenses, said the company. The gradie
The correlation between the cost of an eye exam in New Zealand and what practices charge for it is a weak one, according to the initial findings of a new study.
Sea2see has partnered with the French Sail Grand Prix team (SailGP), providing them with sunglasses made from recycled marine plastic. “The world-class athletes of France SailGP share our passion and commitment to the protection of the oceans for future generations,” said Sea2see founder François va
Reper’s prosthetic iris for traumatic aphakia and aniridia patients is now available in New Zealand via Medix21. The country’s first implantation was completed in Christchurch in December 2021.
Inspired by the success of the mother and daughter collection Tête à Lunettes, Caroline Abram co-created a collection for fathers and sons, Talla and Mini-Talla, with her partner in eyewear and life, Italian designer Gianluca Gualandi.
Researchers at the National University of Singapore have developed a glove patients can use at home to accurately monitor intraocular pressures (IOP).
A ‘sleeping bag’ to help astronauts combat space-associated neuro-ocular syndrome (SANS) has been shown to reduce choroid engorgement in simulated microgravity.
Entering a new digital era of refraction, OPSM is rolling out Essilor’s latest eyecare technology, Clarifye, offering patients a fully digital experience.
Nano 3.0 is the new version of the classic Nano children’s frames, with updated design and technical improvements offering an ‘indestructible’ collection for unstoppable kids aged one to 16, said Spanish company NanoVista. The collection is made with hypoallergenic and non-toxic Siliflex and feature
A study by the Oxford University Hospitals NHS Foundation Trust in the UK has demonstrated the safety of robot-assisted subretinal drug delivery.
Glaukos announced it has enrolled its first patient for phase 2 trials of GLK-302, a pilocarpine-based cream applied to the outer eyelid to treat presbyopia. Glaukos said it expects to enrol 120
A team from US-based Johns Hopkins University have developed a colour-coded test that quickly signals whether therapeutic nanoparticles (NPs) have delivered their cargo into target cells, in the fight